Free Trial
→ Must-See: 5-Second Trump Prediction (From InvestorPlace) (Ad) Free NVS Stock Alerts

Novartis (NVS) SEC Filings & 10K Form

Novartis logo
$97.51 -0.35 (-0.36%)
As of 01/17/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent Novartis SEC Filings

Export to Excel
DateFilerForm TypeView
12/30/2024
5:05 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/25/2024
9:20 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2024
5:20 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2024
3:38 PM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/17/2024
4:08 PM		Novartis (Filer)
Novartis Capital CORP (Filer)
Form 424B5
09/17/2024
1:05 PM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
4:12 PM		Novartis (Subject)
Form FWP
09/16/2024
7:44 AM		Novartis (Filer)
Novartis Capital CORP (Filer)
Form 424B5
09/16/2024
7:12 AM		Novartis (Filer)
Novartis Capital CORP (Filer)
Form F-3ASR
08/15/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC 13D/A
08/13/2024
3:31 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
08/12/2024
2:30 PM		Kowalski Robert William (Reporting)
Novartis (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
7:12 PM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
08/02/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
08/01/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
07/31/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
07/30/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
07/29/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
07/25/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
07/18/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
07/18/2024
5:09 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/11/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
07/05/2024
5:02 AM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T
06/21/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC 13D/A
06/20/2024
2:38 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-C
06/17/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC 13D/A
06/10/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC 13D/A
06/04/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
05/31/2024
5:00 AM		Novartis (Filer)
Form SD
Specialized Disclosure Report  
05/22/2024
11:42 AM		Gal Aharon (Reporting)
Novartis (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
3:31 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
05/07/2024
3:45 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
05/06/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
05/02/2024
3:31 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
04/25/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
04/23/2024
5:06 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/18/2024
3:31 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
04/18/2024
1:33 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC 13D
04/17/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
04/16/2024
4:07 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
Grab This Altcoin Before Trump's Crypto Announcement (Ad)

Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now.

Click here to check it out now
04/15/2024
2:44 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
04/11/2024
5:01 AM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T
02/15/2024
3:15 PM		Novartis (Filer)
Form S-8 POS
02/06/2024
3:52 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-C
02/05/2024
4:06 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-C
02/02/2024
1:18 PM		BlackRock Inc. (Filed by)
Novartis (Subject)
Form SC 13G/A
01/31/2024
6:43 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2024
6:43 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2024
6:44 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2024
6:44 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2024
6:38 AM		Novartis (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
01/31/2024
6:42 AM		Novartis (Filer)
Form IRANNOTICE
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSE:NVS) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners
Last time you’ll see this priced at $1.00
When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...
StocksToTrade | Sponsored
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong
Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...
Brownstone Research | Sponsored
Kamala’s final humiliation
The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...
Porter & Company | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
January 29th - the next big trading catalyst to watch
Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...
Timothy Sykes | Sponsored
Warren Buffett Bets $40 Billion—You Can Get in for $20
I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...
Behind the Markets | Sponsored
Grab This Altcoin Before Trump's Crypto Announcement
The #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...
Crypto 101 Media | Sponsored
Stunning Trump Exec Order Leaked
This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...
Banyan Hill Publishing | Sponsored